rs148419444
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_004655.4(AXIN2):c.1948C>T(p.Arg650Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000359 in 1,613,740 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R650H) has been classified as Likely benign.
Frequency
Consequence
NM_004655.4 missense
Scores
Clinical Significance
Conservation
Publications
- oligodontia-cancer predisposition syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- craniosynostosisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AXIN2 | NM_004655.4 | c.1948C>T | p.Arg650Cys | missense_variant | Exon 8 of 11 | ENST00000307078.10 | NP_004646.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AXIN2 | ENST00000307078.10 | c.1948C>T | p.Arg650Cys | missense_variant | Exon 8 of 11 | 1 | NM_004655.4 | ENSP00000302625.5 | ||
| AXIN2 | ENST00000375702.5 | c.1753C>T | p.Arg585Cys | missense_variant | Exon 6 of 9 | 1 | ENSP00000364854.5 | |||
| AXIN2 | ENST00000618960.4 | c.1753C>T | p.Arg585Cys | missense_variant | Exon 7 of 10 | 5 | ENSP00000478916.1 | |||
| AXIN2 | ENST00000578251.1 | n.170C>T | non_coding_transcript_exon_variant | Exon 1 of 3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152248Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000734 AC: 18AN: 245366 AF XY: 0.0000601 show subpopulations
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461492Hom.: 1 Cov.: 33 AF XY: 0.0000330 AC XY: 24AN XY: 727024 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000112 AC: 17AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Oligodontia-cancer predisposition syndrome Uncertain:1Benign:1
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 15735151) -
AXIN2-related disorder Uncertain:1
The AXIN2 c.1948C>T variant is predicted to result in the amino acid substitution p.Arg650Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.049% of alleles in individuals of African descent in gnomAD and is interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/182009/). This variant could be benign. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at